GlaxoSmithKline
GlaxoSmithKline's consolidated financial statements revealed that, the company's net profit declined by 80 percent year-on-year during 2020.
This agreement is to rehabilitate two existing production lines at the company’s plant.
GSK last week quit the race to buy Pfizer’s consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion.
The U.S. Chamber of Commerce expressed its support for the expansions of the U.S. firms in Egypt.
The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines.
Mobile services provider Vodafone Egypt plans to allocate LE 2 billion ($110 million) for expanding their business in 2017, external relations manager Ayman Essam said Tuesday.
Sahar Nasr mulled with representatives of two international pharmaceutical companies working in Egypt the injection of $128 million investments within the coming period.
